- Home
- NKTR vs GECC Comparison
NKTR vs GECC Comparison
Compare NKTR & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- GECC
- Stock Information
- Founded
- NKTR 1990
- GECC 2016
- Country
- NKTR United States
- GECC United States
- Employees
- NKTR N/A
- GECC N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- GECC Finance: Consumer Services
- Sector
- NKTR Health Care
- GECC Finance
- Exchange
- NKTR Nasdaq
- GECC Nasdaq
- Market Cap
- NKTR 108.3M
- GECC 123.1M
- IPO Year
- NKTR 1994
- GECC N/A
- Fundamental
- Price
- NKTR $23.47
- GECC $10.93
- Analyst Decision
- NKTR Strong Buy
- GECC
- Analyst Count
- NKTR 6
- GECC 0
- Target Price
- NKTR $77.50
- GECC N/A
- AVG Volume (30 Days)
- NKTR 4.6M
- GECC 25.4K
- Earning Date
- NKTR 08-07-2025
- GECC 07-31-2025
- Dividend Yield
- NKTR N/A
- GECC 14.01%
- EPS Growth
- NKTR N/A
- GECC N/A
- EPS
- NKTR N/A
- GECC 0.42
- Revenue
- NKTR $87,248,000.00
- GECC $42,909,000.00
- Revenue This Year
- NKTR N/A
- GECC $32.54
- Revenue Next Year
- NKTR N/A
- GECC N/A
- P/E Ratio
- NKTR N/A
- GECC $25.85
- Revenue Growth
- NKTR N/A
- GECC 18.13
- 52 Week Low
- NKTR $6.48
- GECC $8.87
- 52 Week High
- NKTR $37.38
- GECC $11.39
- Technical
- Relative Strength Index (RSI)
- NKTR 64.13
- GECC 58.25
- Support Level
- NKTR $8.27
- GECC $10.80
- Resistance Level
- NKTR $26.59
- GECC $10.60
- Average True Range (ATR)
- NKTR 3.81
- GECC 0.25
- MACD
- NKTR 0.81
- GECC 0.03
- Stochastic Oscillator
- NKTR 52.67
- GECC 97.10
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.